BIIB Biogen Inc.
$209.83
Biogen Inc. (BIIB) is expected to report earnings on October 28, 2026, before the market open. The consensus earnings estimate is $2.87 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.3% since its last earnings release on July 29, 2026.
Biogen Beat Consensus Estimates
Wednesday, July 29, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 28
Wednesday · Before Open
Earnings Whisper
-
vs $2.87
Rev est $2.57B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$207.15
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Biogen Inc.
Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.
Sector
Healthcare
Industry
Biotechnology